The story of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in sales , its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its market share . While specific pharmaceutical companies may try to capitalize on similar cond